Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,274 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Anchorage Digital Bank released the first official USAT attestation, confirming $17.6 million in reserves backing Tet...
As markets shift in early 2026, dividend-growth stocks offer retirees predictable income. Here are four blue chips wi...
A sweeping poll finds that cost-of-living pressures touch Americans across income levels, including six-figure earner...
A new generation of unmanned systems is changing strategy and markets alike. Investors are watching how the rise comb...
Glamour and money collide at fashion week, but the real story lies in how high-profile families manage their finances...
Elon Musk has signaled an April roll-out for X Money's early public access, intensifying speculation about crypto fea...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
Palantir CEO Alex Karp asserts there was never a domestic surveillance plan in the Anthropic-DoD dispute, detailing t...
Looking to save more while you shop? This expert guide breaks down the best platforms for cash back offers, plus real...
TransFi has secured $19 million in funding to push its cross-border stablecoin payments platform into multiple region...
Netflix charts a high-stakes path, slowing buybacks to fund a debt-heavy growth plan and weighing a marquee deal, as ...